| Bioactivity | AZD-3289 is a potent BACE1 inhibitor with potential Alzheimer's disease inhibitory activity. The application of AZD-3289 is intended to slow the pathological progression of Alzheimer's disease by inhibiting the production of β-amyloid protein. The development of AZD-3289 responds to the need to reduce neurodegenerative changes associated with Alzheimer's disease. As a BACE1 inhibitor, AZD-3289 can effectively reduce the accumulation of β-amyloid peptide in the brain, which may improve cognitive function[1]. |
| CAS | 1227163-49-6 |
| Formula | C24H14F5N5 |
| Molar Mass | 467.39 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Stepping closer to treating Alzheimer's disease patients with BACE1 inhibitor drugs |
AZD-3289
CAS: 1227163-49-6 F: C24H14F5N5 W: 467.39
AZD-3289 is a potent BACE1 inhibitor with potential Alzheimer's disease inhibitory activity. The application of AZD-3289
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.